Nature Catalysis will bring together researchers from across all chemistry and related fields. It will publish work on homogeneous catalysis, heterogeneous catalysis, and biocatalysts, incorporating both fundamental and applied studies. Nature Catalysis will provide coverage of the science and business of catalysis research, creating a unique journal for scientists, engineers, and researchers in industry.
American Chemical Society•ISSN: 2379-3694•United States
10.9
Clarivate IF
ACS Sensors is a peer-reviewed research journal that is devoted to the dissemination of new and original knowledge on all aspects of sensor science that selectively sense chemical or biological species or processes. Articles may address conceptual advances in sensing that are applicable to many types of analytes or application papers which report on the use of an existing sensing concept in a new way or for a new analyte. Application papers should demonstrate the use of the sensor in complex samples, show it is fit-for-purpose, and exhibit a correlation of the sensor’s performance with an existing analytical method. Papers may focus on sensor development for commercialization or developing sensors that are used to provide new scientific knowledge. Articles may be entirely theoretical with regard to sensing, or they may report experimental results.
Food Structure is the premier international forum devoted to the publication of high-quality original research on food structure. The focus of this journal is on food structure in the context of its relationship with molecular composition, processing and macroscopic properties (e.g., shelf stability, sensory properties, etc.). Manuscripts that only report qualitative findings and micrographs and that lack sound hypothesis-driven, quantitative structure-function research are not accepted. Significance of the research findings for the food science community and/or industry must also be highlighted.
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.